Search results
We found 6 document(s) tagged with Multivariate analysis
Prostate Cancer Antigen 3 (PCA3) is an independent and significant predictor for pathologically insignificant Prostate Cancer (PCa) in men undergoing radical prostatectomy
This poster was presented by Dr. Ward at the 24th annual congress of the European Association of Urology (EAU), 17-21 March 2009 in Stockholm, Sweden.
Submitted by Ismar Healthcare on 2009/04/02- Keywords:
- Active surveillance
- Gleason score
- PCA3 Score
- Multivariate analysis
- Prostate cancer
- PSA
- Significant cancer
- Prostatectomy
PCA3 represents a clinically meaningful predictor of prostate cancer at repeat biopsy
This abstract was presented as a poster at the 23rd annual meeting of the European Association of Urology (EAU), 26-29 March 2008, Milan, Italy.
Submitted by Ismar Healthcare on 2009/09/17- Keywords:
- DRE
- PCA3
- PCA3 Score
- Prostate cancer
- Prostate volume
- PSA
- Repeat biopsy
- Test
- Multivariate analysis
- Nomogram
- Univariate analysis
Urinary markers for prostate cancer (Presentation in French)
This presentation was given by Dr. de la Taille at the 102nd annual meeting of the French Association of Urology, 19-22 November 2008, Paris, France
Submitted by Ismar Healthcare on 2009/04/02- Keywords:
- Diagnosis
- First biopsy
- Gleason score
- Multivariate analysis
- PCA3
- Prostate cancer
- Prostate cancer specific
- PSA
- Repeat biopsy
- Sensitivity
- Significant cancer
- Specificity
- Test
The PCA3 test in the diagnosis of prostate cancer
This presentation was given by Dr. M. Roobol at the 24th annual congress of the EAU, 17-21 March 2009 in Stockholm, Sweden
Submitted by Ismar Healthcare on 2009/04/02- Keywords:
- Biopsy
- Diagnosis
- Gleason score
- Multivariate analysis
- ROC curve
- PCA3
- PCA3 Score
- Prostate cancer
- Prostate cancer specific
- Prostate volume
- PSA
- Sensitivity
- Significant cancer
- Specificity
- Tumour volume
Analysis of REDUCE trial confirms that the PCA3 Assay can help guide repeat biopsy decisions
This poster was presented by J Groskopf J at the ASCO 2010 Genitourinary Cancers Symposium, 5-7 March 2010, San Francisco, California, USA
Submitted by on 2010/07/27The PCA3 Score is not affected by dutasteride; analysis of the REDUCE trial
This poster was presented by R Rittmaster at the ASCO 2010 Genitourinary Cancers Symposium, 5-7 March 2010, San Francisco, California, USA
Submitted by on 2010/07/27